Statement of Changes in Beneficial Ownership (4)
12 Setembro 2019 - 4:04PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Hancock Richard B |
2. Issuer Name and Ticker or Trading Symbol
Avid Bioservices, Inc.
[
CDMO
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Interim President & CEO
|
(Last)
(First)
(Middle)
2642 MICHELLE DRIVE, SUITE 200 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
9/10/2019
|
(Street)
TUSTIN, CA 92780
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock, $0.001 par value
|
9/10/2019
|
|
P
|
|
3800
|
A
|
$5.08
|
3800
|
D
|
|
Common Stock, $0.001 par value
|
9/10/2019
|
|
P
|
|
1300
|
A
|
$5.09
|
5100
|
D
|
|
Common Stock, $0.001 par value
|
9/10/2019
|
|
P
|
|
200
|
A
|
$5.095
|
5300
|
D
|
|
Common Stock, $0.001 par value
|
9/10/2019
|
|
P
|
|
4700
|
A
|
$5.10
|
10000
|
D
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code (Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)
|
8. Price of Derivative Security (Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Hancock Richard B 2642 MICHELLE DRIVE, SUITE 200 TUSTIN, CA 92780
|
X
|
|
Interim President & CEO
|
|
Signatures
|
/s/ Stephen Hedberg, by Power of Attorney for Richard B. Hancock
|
|
9/12/2019
|
**Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person, see Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Avid Bioservices (NASDAQ:CDMOP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Avid Bioservices (NASDAQ:CDMOP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 Terça, 2 de Julho de 2024 (2 semanas atrás) • GlobeNewswire Inc. |
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 Segunda, 1 de Julho de 2024 (2 semanas atrás) • GlobeNewswire Inc. |
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance Quinta, 23 de Maio de 2024 (2 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices to Participate at Upcoming Investor Conferences Terça, 7 de Maio de 2024 (2 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 Quarta, 24 de Abril de 2024 (3 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q Quarta, 20 de Março de 2024 (4 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes Quinta, 7 de Março de 2024 (4 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Announces Proposed Private Placement of Convertible Notes Quarta, 6 de Março de 2024 (4 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 Quarta, 6 de Março de 2024 (4 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023 Quinta, 7 de Dezembro de 2023 (7 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023 Quinta, 30 de Novembro de 2023 (8 meses atrás) • GlobeNewswire Inc. |
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs Quarta, 8 de Novembro de 2023 (8 meses atrás) • GlobeNewswire Inc. |
Mais Notícias de Avid Bioservices, Inc.
Parece que você não está logado. Clique no botão abaixo para se logar e ver seu histórico recente.